Head-to-head · WeighScore
Claya vs Rex MD
By GLP-1 ScorecardUpdated
Score comparison
Rex MD has the higher recorded score — 70.2/100 to 62.8/100.
Rex MD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Rex MD offers branded GLP-1 care through its men's-health platform, with a current Wegovy pill bundle starting at $349/month.
Before you choose
Before comparing the headline prices, the Claya review and the Rex MD review set out what each semaglutide figure in the table below covers, including whether the medication is a brand-name product billed by a pharmacy. Brand-name and compounded prices are different products, so set like against like before treating either one as cheaper.
If neither one fits, Claya vs Willow and CoreAge Rx vs Rex MD compare each of them with another graded program, and the list of alternatives to Claya ranks the programs closest to Claya on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
Of the sellers that pay us a commission, the System Labs review covers one graded close to these two, at 68.4/100. That relationship never changes a grade, and the review lists what we could not verify.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Claya | Rex MD |
|---|---|---|
| WeighScore | 62.8/100 | 70.2/100 |
| Grade | C | C |
| Site position | #286 | #119 |
| Semaglutide | $299/mo (compounded) | $349/mo (starting price, brand-name Wegovy pill with provider care) |
| Tirzepatide | $299/mo (compounded) | Not disclosed (brand Zepbound access listed) |
| Coverage | Coverage not published | All 50 states (platform claim; confirm treatment availability) |
| Brand-name access | Not confirmed | Yes |
| Oral / sublingual | Yes | Yes |
Strengths
- Two named licensed clinicians (Habashy, NMD MS and Barber, MD PhD) — rare transparency for compounded GLP-1
- Two named pharmacy partners with full addresses (RedRock, UT and Healthware, KY)
- Both injectable and oral-tablet forms offered for semaglutide and tirzepatide
- Weight-loss money-back guarantee published on the homepage
- Free expedited shipping included in the monthly price
What to consider
- States-served list not disclosed — you must check at checkout
- LegitScript certification status not displayed
- Corporate legal entity not disclosed on the site or privacy policy
- Oral compounded tablets have weaker efficacy data than injectable semaglutide
- Intro pricing is higher at refill ($299), erasing the first-month advantage
Site position #119 · C
Strengths
- Current Wegovy pill offer includes medication and provider care
- Advertises the same pill price across its listed titration strengths
- Wegovy pen and Zepbound access are also listed
- FAQ describes overnight shipping for weight-management prescriptions
What to consider
- Does not accept insurance
- FAQ also describes a separate $75 starting program price with variable medication costs
- Current Wegovy pen and Zepbound totals were not verified
- Automatic-renewal terms require attention; prescription medications are nonreturnable and nonrefundable
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.